AzTrials
AzTrials

Mechanical VentilationPhase 4NCT00813839

Automated Ventilator Controlled Weaning vs Daily Spontaneous Breathing Trial in Difficult to Wean ICU Patients

A Phase 4 study testing daily weaning trails in people with Mechanical Ventilation and Weaning, run by University of California, San Francisco at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study will compare Drager Smart Care (SC), a commercially available automated ventilator controlled weaning mode to the current daily spontaneous breathing trial (SBT) weaning protocol. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mechanical Ventilation, Weaning
What is being tested?
daily weaning trails
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Nov 2008to Oct 2011
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Intubated with endotracheal tube
  • Requiring mechanical ventilation for > 72 hours
  • Meets weaning criteria: Improvement or resolution of the underlying process that precipitated need for mechanical ventilation, PaO2 ≥ 60 mm Hg on PEEP and FiO2 Requirements of ≤ 8 cm H2O and FiO2 ≤ 0.50, Stable oxygenation: PEEP and FiO2 requirements not increased in the past 24 hrs, Ability to initiate an inspiratory effort and trigger the ventilator, Subject enrollment approved by the primary service attending physician

Who cannot join

  • Pregnancy
  • Patients with tracheostomy or planned tracheostomy prior to attempt to extubate
  • Patients with known airway patency issues that are anticipated to delay extubation.
  • Patients with neurological injury in whom care is likely to be withdrawn
  • Patients with cervical spinal cord injury.
  • Prospective subject or surrogate consenter does not fully understand the implications of the study because of a language barrier.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • San Francisco General Hospital, UCSF Dept. of Anesthesia

    San Francisco, California, 94110

Other trials in United States

About this study

Official title: Comparison of Automated Ventilator Controlled Weaning to Daily Spontaneous Breathing Trial Weaning Protocol in ICU Patients Following Prolonged Mechanical Ventilation.

This study will compare Drager Smart Care (SC), a commercially available automated ventilator controlled weaning mode to the current daily spontaneous breathing trial (SBT) weaning protocol. The study is designed to determine if automated ventilator controlled weaning can reduce total duration of intubation following mechanical ventilation in ICU patients requiring prolonged mechanical ventilation (>72 hours).

Being tested
daily weaning trails
Keywords
SmartCare, Spontaneous Breathing Trials, Mechanical Ventilation, Weaning, Patients requiring prolonged mechanical ventilation (>72 hours)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • daily weaning trailsOther

    daily SmartCare vs SBT until extubation criteria met

Study groups in NCT00813839
Study groupRoleWhat they receive
1 SmartCareExperimentalautomated ventilator controlled adjustment of pressure support
Receives: Other: daily weaning trails
2 spontaneous breathing TrialActive comparatordaily SBT on minimum pressure support
Receives: Other: daily weaning trails

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. weaning time to successful spontaneous breathing trial

    Measured: 28 days or extubation

  2. weaning time to successful extubation

    Measured: 28 days or extubation

  3. ventilator weaning days

    Measured: 28 days or extubation

  4. total duration of ventilatory support

    Measured: 28 days or extubation

Secondary outcomes (4)
  1. reintubations within 48 hours

    Measured: 48 hrs

  2. sedation and analgesic requirements

    Measured: 28 days or extubation

  3. ICU and hospital length of stay

    Measured: total time of ICU and hospital stay

  4. clinical staff time requirements

    Measured: during active weaning period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2008 (estimated)
  2. Study startNov 2008
  3. Primary completionOct 2011
  4. Study completionOct 2011

Why it stopped: for inability to enroll subjects.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00813839
Sponsor's protocol ID
H60971-32402-02
Status last verified
May 2015
First submitted
19 Dec 2008
Last updated
8 May 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing daily weaning trails in people with Mechanical Ventilation and Weaning, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 8 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

weaning time to successful spontaneous breathing trial (time frame: 28 days or extubation). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in